As cold and flu season ramps up, health care experts are once again on high alert for the possibility of a tripledemic, or a surge brought on by the respiratory viruses that cause COVID-19, the flu, and respiratory syncytial virus, or RSV. The good news is that this year, health officials have more tools at their disposal to combat them.
Americans ages 6 months and older are eligible to receive the newest COVID-19 vaccine and the annual flu vaccine. In addition, this year the Food and Drug Administration approved the first vaccine against RSV for use in late pregnancy and adults 60 years of age and older.
